Cargando…
Coronavirus Disease 2019 and Smoking: How and Why We Implemented a Tobacco Treatment Campaign
Smoking is associated with one of five deaths in the United States. Multimodality tobacco treatment increases rates of successful cessation by at least 20%. The coronavirus disease 2019 pandemic has put a halt to many inpatient and outpatient medical visits that have been deemed nonessential, includ...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297684/ https://www.ncbi.nlm.nih.gov/pubmed/32561438 http://dx.doi.org/10.1016/j.chest.2020.06.013 |
_version_ | 1783547056270344192 |
---|---|
author | Lang, Adam Edward Yakhkind, Aleksandra |
author_facet | Lang, Adam Edward Yakhkind, Aleksandra |
author_sort | Lang, Adam Edward |
collection | PubMed |
description | Smoking is associated with one of five deaths in the United States. Multimodality tobacco treatment increases rates of successful cessation by at least 20%. The coronavirus disease 2019 pandemic has put a halt to many inpatient and outpatient medical visits that have been deemed nonessential, including tobacco treatment. The transition to telehealth has been wrought with challenges. Although data on the association between coronavirus disease 2019 and tobacco products are mixed, the overall health consequences of tobacco point towards increased risk of morbidity and death that is associated with the virus. This leaves smoking as one of the few readily modifiable risk factors in an environment understandably not set up to prioritize cessation. A military health facility on Fort Eustis in Virginia runs a successful tobacco treatment program and adapted it to pandemic times. This article describes the process and lessons learned from this initiative. The model is applicable and scalable to government and civilian health centers as health care adapts to a new normal. |
format | Online Article Text |
id | pubmed-7297684 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American College of Chest Physicians |
record_format | MEDLINE/PubMed |
spelling | pubmed-72976842020-06-17 Coronavirus Disease 2019 and Smoking: How and Why We Implemented a Tobacco Treatment Campaign Lang, Adam Edward Yakhkind, Aleksandra Chest Thoracic Oncology: How I Do It Smoking is associated with one of five deaths in the United States. Multimodality tobacco treatment increases rates of successful cessation by at least 20%. The coronavirus disease 2019 pandemic has put a halt to many inpatient and outpatient medical visits that have been deemed nonessential, including tobacco treatment. The transition to telehealth has been wrought with challenges. Although data on the association between coronavirus disease 2019 and tobacco products are mixed, the overall health consequences of tobacco point towards increased risk of morbidity and death that is associated with the virus. This leaves smoking as one of the few readily modifiable risk factors in an environment understandably not set up to prioritize cessation. A military health facility on Fort Eustis in Virginia runs a successful tobacco treatment program and adapted it to pandemic times. This article describes the process and lessons learned from this initiative. The model is applicable and scalable to government and civilian health centers as health care adapts to a new normal. American College of Chest Physicians 2020-10 2020-06-17 /pmc/articles/PMC7297684/ /pubmed/32561438 http://dx.doi.org/10.1016/j.chest.2020.06.013 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Thoracic Oncology: How I Do It Lang, Adam Edward Yakhkind, Aleksandra Coronavirus Disease 2019 and Smoking: How and Why We Implemented a Tobacco Treatment Campaign |
title | Coronavirus Disease 2019 and Smoking: How and Why We Implemented a Tobacco Treatment Campaign |
title_full | Coronavirus Disease 2019 and Smoking: How and Why We Implemented a Tobacco Treatment Campaign |
title_fullStr | Coronavirus Disease 2019 and Smoking: How and Why We Implemented a Tobacco Treatment Campaign |
title_full_unstemmed | Coronavirus Disease 2019 and Smoking: How and Why We Implemented a Tobacco Treatment Campaign |
title_short | Coronavirus Disease 2019 and Smoking: How and Why We Implemented a Tobacco Treatment Campaign |
title_sort | coronavirus disease 2019 and smoking: how and why we implemented a tobacco treatment campaign |
topic | Thoracic Oncology: How I Do It |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297684/ https://www.ncbi.nlm.nih.gov/pubmed/32561438 http://dx.doi.org/10.1016/j.chest.2020.06.013 |
work_keys_str_mv | AT langadamedward coronavirusdisease2019andsmokinghowandwhyweimplementedatobaccotreatmentcampaign AT yakhkindaleksandra coronavirusdisease2019andsmokinghowandwhyweimplementedatobaccotreatmentcampaign |